Earnings Preview For Astria Therapeutics
Portfolio Pulse from Benzinga Insights
Astria Therapeutics (NASDAQ:ATXS) is set to release its latest quarterly earnings report on November 13, 2023. Analysts estimate an earnings per share (EPS) of $-0.49. The company's past performance shows a trend of beating EPS estimates, which has led to increases in share price. However, the stock has been down 45.02% over the last 52-week period.
November 10, 2023 | 2:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Astria Therapeutics is expected to report an EPS of $-0.49. The company's history of beating EPS estimates could potentially lead to a short-term increase in share price, despite a 45.02% decrease over the last 52 weeks.
Astria Therapeutics has a history of beating EPS estimates, which has previously led to increases in share price. However, the stock has been down 45.02% over the last 52 weeks, indicating a bearish sentiment among long-term shareholders. The upcoming earnings report could potentially influence the stock's short-term performance, but the overall trend appears negative.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100